Medical Weight Loss for Mount Prospect, Illinois Residents

Mount Prospect, Illinois residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Mount Prospect through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Open to all of Illinois, including Mount Prospect: our Costa Mesa, California physicians treat patients statewide by telehealth, so distance from our office never changes the care you receive. Doctor review just $119 (medication separate).

Why Mount Prospect Residents Choose New Hope Weight Loss

We made New Hope easy to start without making it less serious. A Mount Prospect patient can go from first visit to a physician-approved plan without insurance paperwork, prior authorizations, or a single drive to an office. The $119 review with Dr. Anjmun Sharma is flat, the medication price is published, and the whole thing happens by telehealth. Low friction to begin, real medicine once you do, the same standard everyone in Illinois gets.

Medical weight loss for Mount Prospect is handled end-to-end online: intake, the $119 physician review with Dr. Sharma, dose titration, and follow-ups, all by secure video, with no drive and no pharmacy line.

Your zip code in Mount Prospect, Illinois does not change the medicine or the doctor, only the way you connect, since Dr. Anjmun Sharma supervises every patient remotely from Costa Mesa. We care for patients throughout downtown Mount Prospect and the northwest Chicago suburbs. From your first question to your ongoing refills, the whole Illinois experience is built to feel personal, private, and genuinely supported.

Your zip code inside Illinois does not raise or lower the price, and it does not move you down a waitlist, because the whole program runs remotely. If you and Dr. Sharma decide tirzepatide fits your goals, Mount Prospect patients can begin from $233 per month, billed apart from your initial $119 visit. From the big cities to the small towns of Illinois, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic.

GLP-1 Weight Loss Programs Available

Which GLP-1 program is right for you?

Our 90-Day Metabolic Reset runs on semaglutide, the same active ingredient as Wegovy and Ozempic. It starts at $166 a month, or $499 for 90 days, and branded-drug trials reported average loss near 15 to 17 percent. Because compounded semaglutide is not FDA-approved or brand-identical, results vary. Dr. Sharma guides every Mount Prospect patient by telehealth.

And if you want more horsepower

Tirzepatide, from $233 a month, adds GIP to the usual GLP-1 action. In branded-drug trials, dose-qualified participants reached up to 22.5 percent loss, which is not the typical outcome. It shares its active ingredient with Mounjaro and Zepbound.

A $119 physician review starts the process. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.

How Telehealth Works for Mount Prospect

Step 1: The quiz. Tell us about your health history, current weight, and goals through a quick online intake.

Step 2: The video visit. Dr. Sharma reviews your intake and meets you by secure video, usually within 48 hours, to discuss whether compounded semaglutide or tirzepatide is a fit. Results vary from person to person.

Step 3: Delivery. A state-licensed 503(a) pharmacy ships your medication to your Mount Prospect address in cold-pack packaging.

Step 4: Follow-ups. You stay in touch by video as you progress.

Frequently Asked Questions, Mount Prospect

Where is the closest New Hope Weight Loss to Mount Prospect?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Mount Prospect, Illinois patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Mount Prospect?

It is not. We run a complete telehealth model, so people in Mount Prospect handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Mount Prospect using cold-pack insulation that keeps it stable until it reaches you.

What should a Mount Prospect patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Mount Prospect patients are not charged any extra distance fee.

What areas of Mount Prospect do you serve?

We serve patients from across Mount Prospect by telehealth, including downtown Mount Prospect and the northwest Chicago suburbs.

How is medication shipped to Mount Prospect patients?

After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Mount Prospect address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.

Mount Prospect Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Mount Prospect, Illinois by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.